PMC:1064873 / 34584-35574
Annnotations
LappsTest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30689 | 912-922 | Protein | denotes | SOCS3 gene |
| T30688 | 844-849 | Protein | denotes | STAT3 |
| T30687 | 794-799 | Protein | denotes | STAT3 |
| T30686 | 779-783 | Protein | denotes | IL-6 |
| T30685 | 619-646 | Protein | denotes | anti-IL-6 receptor antibody |
| T30684 | 408-412 | Protein | denotes | IL-6 |
| T30683 | 262-291 | Protein | denotes | SOCS1 predominance over SOCS3 |
| T30682 | 218-223 | Protein | denotes | STAT3 |
| T30681 | 186-191 | Protein | denotes | STAT3 |
| T30680 | 136-141 | Protein | denotes | STAT3 |
| T30679 | 78-83 | Protein | denotes | IL-10 |
| T30678 | 0-4 | Protein | denotes | CD4+ |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 15535835-12672180-4156942 | 470-472 | 12672180 | denotes | 50 |
| 15535835-12483717-4156943 | 681-683 | 12483717 | denotes | 51 |
| 15535835-11748261-4156944 | 986-988 | 11748261 | denotes | 37 |
biosemtest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30931 | 713-717 | UMLS/C0323983 | denotes | his |
| T30930 | 331-338 | UMLS/C0039869 | denotes | hought |
| T30929 | 527-532 | UMLS/C1149215 | denotes | L-10 |
| T30928 | 439-444 | UMLS/C1149215 | denotes | L-10 |
| T30927 | 172-177 | UMLS/C1149215 | denotes | L-10- |
| T30926 | 78-83 | UMLS/C1149215 | denotes | IL-10 |
| T30925 | 105-115 | UMLS/C1548180 | denotes | roduction, |
| T30924 | 386-390 | UMLS/C1299351 | denotes | igh |
| T30923 | 64-74 | UMLS/C1522618 | denotes | resistance |
| T30922 | 495-499 | UMLS/C0449719 | denotes | art |
| T30921 | 64-74 | UMLS/C0237834 | denotes | resistance |
| T30920 | 827-834 | UMLS/C0087111 | denotes | herapy |
| T30919 | 718-725 | UMLS/C0087111 | denotes | herapy |
| T30918 | 445-454 | UMLS/C0087111 | denotes | reatment |
| T30917 | 639-647 | UMLS/C0003241 | denotes | ntibody |
| T30916 | 445-454 | UMLS/C1522326 | denotes | reatment |
| T30915 | 972-985 | UMLS/C0599779 | denotes | nimal models |
| T30914 | 780-784 | UMLS/C1149241 | denotes | L-6- |
| T30913 | 409-413 | UMLS/C1149241 | denotes | L-6. |
| T30912 | 726-729 | UMLS/C0454788 | denotes | ay |
| T30911 | 475-478 | UMLS/C0454788 | denotes | ay |
| T30910 | 726-729 | UMLS/C0337876 | denotes | ay |
| T30909 | 475-478 | UMLS/C0337876 | denotes | ay |
| T30908 | 360-365 | UMLS/C0231290 | denotes | fter |
| T30907 | 702-709 | UMLS/C2348382 | denotes | ffects |
| T30906 | 913-923 | UMLS/C1426212 | denotes | OCS3 gene, |
| T30905 | 287-292 | UMLS/C1426212 | denotes | OCS3. |
| T30904 | 556-565 | UMLS/C0332257 | denotes | ncluding |
| T30903 | 419-426 | UMLS/C0439801 | denotes | imited |
| T30902 | 851-861 | UMLS/C1879547 | denotes | ctivation |
| T30901 | 801-811 | UMLS/C1879547 | denotes | ctivation. |
| T30888 | 702-709 | UMLS/C1280500 | denotes | ffects |
| T30887 | 835-844 | UMLS/C0599894 | denotes | argeting |
| T30886 | 419-426 | UMLS/C1549479 | denotes | imited |
| T30885 | 495-499 | UMLS/C1552020 | denotes | art |
| T30884 | 896-905 | UMLS/C0205263 | denotes | nduction |
| T30883 | 345-352 | UMLS/C0205263 | denotes | nduced |
| T30882 | 556-565 | UMLS/C2700399 | denotes | ncluding |
| T30881 | 386-390 | UMLS/C0205250 | denotes | igh |
| T30880 | 225-234 | UMLS/C1710082 | denotes | ignaling |
| T30879 | 495-499 | UMLS/C1148523 | denotes | art |
| T30878 | 785-794 | UMLS/C0851827 | denotes | ependent |
| T30877 | 736-745 | UMLS/C1882115 | denotes | ormalize |
| T30876 | 835-844 | UMLS/C1521840 | denotes | argeting |
| T30875 | 862-866 | UMLS/C0043177 | denotes | ill |
| T30874 | 391-405 | UMLS/C0086045 | denotes | oncentrations |
| T30873 | 360-365 | UMLS/C0687676 | denotes | fter |
| T30872 | 527-532 | UMLS/C1522550 | denotes | L-10 |
| T30871 | 439-444 | UMLS/C1522550 | denotes | L-10 |
| T30870 | 172-177 | UMLS/C1522550 | denotes | L-10- |
| T30869 | 78-83 | UMLS/C1522550 | denotes | IL-10 |
| T30868 | 527-532 | UMLS/C1334098 | denotes | L-10 |
| T30867 | 439-444 | UMLS/C1334098 | denotes | L-10 |
| T30866 | 172-177 | UMLS/C1334098 | denotes | L-10- |
| T30865 | 78-83 | UMLS/C1334098 | denotes | IL-10 |
| T30864 | 896-905 | UMLS/C1621983 | denotes | nduction |
| T30863 | 366-373 | UMLS/C1547296 | denotes | hronic |
| T30862 | 386-390 | UMLS/C1561957 | denotes | igh |
| T30861 | 386-390 | UMLS/C1561958 | denotes | igh |
| T30860 | 766-776 | UMLS/C1628982 | denotes | nhibition |
| T30859 | 84-94 | UMLS/C1628982 | denotes | inhibition |
| T30858 | 780-784 | UMLS/C0021760 | denotes | L-6- |
| T30857 | 409-413 | UMLS/C0021760 | denotes | L-6. |
| T30856 | 163-171 | UMLS/C0684336 | denotes | mpaired |
| T30855 | 657-665 | UMLS/C0700287 | denotes | eported |
| T30854 | 672-680 | UMLS/C0030705 | denotes | atients |
| T30853 | 461-469 | UMLS/C0030705 | denotes | atients |
| T30852 | 28-36 | UMLS/C0030705 | denotes | patients |
| T30851 | 238-246 | UMLS/C2362652 | denotes | ossibly |
| T30850 | 780-784 | UMLS/C1334122 | denotes | L-6- |
| T30849 | 409-413 | UMLS/C1334122 | denotes | L-6. |
| T30848 | 845-850 | UMLS/C1367307 | denotes | TAT3 |
| T30847 | 795-800 | UMLS/C1367307 | denotes | TAT3 |
| T30846 | 219-224 | UMLS/C1367307 | denotes | TAT3 |
| T30845 | 187-192 | UMLS/C1367307 | denotes | TAT3 |
| T30844 | 137-142 | UMLS/C1367307 | denotes | TAT3 |
| T30843 | 366-373 | UMLS/C0205191 | denotes | hronic |
| T30842 | 300-313 | UMLS/C1704258 | denotes | bnormalities |
| T30841 | 672-680 | UMLS/C1578479 | denotes | atients |
| T30840 | 461-469 | UMLS/C1578479 | denotes | atients |
| T30839 | 28-36 | UMLS/C1578479 | denotes | patients |
| T30838 | 672-680 | UMLS/C1578483 | denotes | atients |
| T30837 | 461-469 | UMLS/C1578483 | denotes | atients |
| T30836 | 28-36 | UMLS/C1578483 | denotes | patients |
| T30835 | 596-616 | UMLS/C2348767 | denotes | herapeutic efficacy |
| T30834 | 672-680 | UMLS/C1578480 | denotes | atients |
| T30833 | 461-469 | UMLS/C1578480 | denotes | atients |
| T30832 | 28-36 | UMLS/C1578480 | denotes | patients |
| T30831 | 672-680 | UMLS/C1578481 | denotes | atients |
| T30830 | 461-469 | UMLS/C1578481 | denotes | atients |
| T30829 | 28-36 | UMLS/C1578481 | denotes | patients |
| T30828 | 445-454 | UMLS/C1533734 | denotes | reatment |
| T30827 | 672-680 | UMLS/C1578486 | denotes | atients |
| T30826 | 461-469 | UMLS/C1578486 | denotes | atients |
| T30825 | 28-36 | UMLS/C1578486 | denotes | patients |
| T30824 | 672-680 | UMLS/C1578484 | denotes | atients |
| T30823 | 461-469 | UMLS/C1578484 | denotes | atients |
| T30822 | 28-36 | UMLS/C1578484 | denotes | patients |
| T30821 | 672-680 | UMLS/C1578485 | denotes | atients |
| T30820 | 461-469 | UMLS/C1578485 | denotes | atients |
| T30819 | 28-36 | UMLS/C1578485 | denotes | patients |
| T30818 | 639-647 | UMLS/C0021027 | denotes | ntibody |
| T30817 | 282-286 | UMLS/C0205136 | denotes | ver |
| T30816 | 317-323 | UMLS/C1561511 | denotes | ctive |
| T30815 | 18-24 | UMLS/C1561511 | denotes | active |
| T30814 | 317-323 | UMLS/C1561512 | denotes | ctive |
| T30813 | 18-24 | UMLS/C1561512 | denotes | active |
| T30812 | 225-234 | UMLS/C0037083 | denotes | ignaling |
| T30811 | 317-323 | UMLS/C1561513 | denotes | ctive |
| T30810 | 18-24 | UMLS/C1561513 | denotes | active |
| T30809 | 445-454 | UMLS/C1705169 | denotes | reatment |
| T30808 | 691-694 | UMLS/C0205447 | denotes | ne |
| T30807 | 672-680 | UMLS/C1550655 | denotes | atients |
| T30806 | 461-469 | UMLS/C1550655 | denotes | atients |
| T30805 | 28-36 | UMLS/C1550655 | denotes | patients |
| T30804 | 785-794 | UMLS/C1701901 | denotes | ependent |
| T30803 | 813-817 | UMLS/C0205172 | denotes | ore |
| T30802 | 556-565 | UMLS/C1552866 | denotes | ncluding |
| T30801 | 374-385 | UMLS/C0332157 | denotes | xposure to |
| T30800 | 317-323 | UMLS/C0205177 | denotes | ctive |
| T30799 | 18-24 | UMLS/C0205177 | denotes | active |
| T30798 | 845-850 | UMLS/C0253050 | denotes | TAT3 |
| T30797 | 795-800 | UMLS/C0253050 | denotes | TAT3 |
| T30796 | 219-224 | UMLS/C0253050 | denotes | TAT3 |
| T30795 | 187-192 | UMLS/C0253050 | denotes | TAT3 |
| T30794 | 137-142 | UMLS/C0253050 | denotes | TAT3 |
| T30793 | 419-426 | UMLS/C0205189 | denotes | imited |
| T30792 | 386-390 | UMLS/C1522410 | denotes | igh |
| T30791 | 317-323 | UMLS/C2347179 | denotes | ctive |
| T30790 | 18-24 | UMLS/C2347179 | denotes | active |
| T30789 | 64-74 | UMLS/C0683598 | denotes | resistance |
| T30788 | 536-554 | UMLS/C0440752 | denotes | nflammatory cells, |
| T30787 | 527-532 | UMLS/C0085295 | denotes | L-10 |
| T30786 | 439-444 | UMLS/C0085295 | denotes | L-10 |
| T30785 | 172-177 | UMLS/C0085295 | denotes | L-10- |
| T30784 | 78-83 | UMLS/C0085295 | denotes | IL-10 |
| T30783 | 419-426 | UMLS/C1549649 | denotes | imited |
| T30782 | 766-776 | UMLS/C0021467 | denotes | nhibition |
| T30781 | 84-94 | UMLS/C0021467 | denotes | inhibition |
| T30780 | 766-776 | UMLS/C0021469 | denotes | nhibition |
| T30779 | 84-94 | UMLS/C0021469 | denotes | inhibition |
| T30778 | 827-834 | UMLS/C0039798 | denotes | herapy |
| T30777 | 718-725 | UMLS/C0039798 | denotes | herapy |
| T30776 | 445-454 | UMLS/C0039798 | denotes | reatment |
| T30775 | 813-817 | UMLS/C0439064 | denotes | ore |
| T30774 | 178-186 | UMLS/C0127400 | denotes | ediated |
| T30773 | 733-735 | UMLS/C0319022 | denotes | o |
| T30772 | 524-526 | UMLS/C0319022 | denotes | o |
| T30771 | 339-341 | UMLS/C0319022 | denotes | o |
| T30770 | 121-123 | UMLS/C0319022 | denotes | o |
| T30769 | 75-77 | UMLS/C0319022 | denotes | to |
| T30768 | 178-186 | UMLS/C0086597 | denotes | ediated |
| T30767 | 639-647 | UMLS/C1621287 | denotes | ntibody |
| T30766 | 657-665 | UMLS/C1709908 | denotes | eported |
| T30765 | 419-426 | UMLS/C0449295 | denotes | imited |
| T30764 | 41-54 | UMLS/C1880022 | denotes | characterized |
| T30763 | 827-834 | UMLS/C1363945 | denotes | herapy |
| T30762 | 718-725 | UMLS/C1363945 | denotes | herapy |
| T30761 | 947-950 | UMLS/C2348947 | denotes | as |
| T30760 | 648-651 | UMLS/C2348947 | denotes | as |
| T30759 | 317-323 | UMLS/C1553875 | denotes | ctive |
| T30758 | 18-24 | UMLS/C1553875 | denotes | active |
| T30757 | 317-323 | UMLS/C1561510 | denotes | ctive |
| T30756 | 18-24 | UMLS/C1561510 | denotes | active |
| T30755 | 317-323 | UMLS/C1561509 | denotes | ctive |
| T30754 | 18-24 | UMLS/C1561509 | denotes | active |
| T30753 | 366-373 | UMLS/C1555457 | denotes | hronic |
| T30752 | 317-323 | UMLS/C1561508 | denotes | ctive |
| T30751 | 18-24 | UMLS/C1561508 | denotes | active |
| T30750 | 317-323 | UMLS/C1561507 | denotes | ctive |
| T30749 | 18-24 | UMLS/C1561507 | denotes | active |
| T30748 | 746-753 | UMLS/C0039194 | denotes | cells |
| T30747 | 566-573 | UMLS/C0039194 | denotes | cells. |
| T30746 | 5-12 | UMLS/C0039194 | denotes | T cells |
| T30745 | 883-890 | UMLS/C1707959 | denotes | xample, |
| T30744 | 143-158 | UMLS/C0031715 | denotes | hosphorylation |
| T30743 | 818-826 | UMLS/C0205369 | denotes | pecific |
| T30742 | 630-638 | UMLS/C0597357 | denotes | eceptor |
| T30741 | 419-426 | UMLS/C2349209 | denotes | imited |
| T30740 | 317-323 | UMLS/C1547419 | denotes | ctive |
| T30739 | 18-24 | UMLS/C1547419 | denotes | active |
| T30738 | 495-499 | UMLS/C1292711 | denotes | art |
| T30737 | 391-405 | UMLS/C1446561 | denotes | oncentrations |
| T30736 | 163-171 | UMLS/C0221099 | denotes | mpaired |
| T30900 | 193-203 | UMLS/C1879547 | denotes | ctivation. |
| T30899 | 862-866 | UMLS/C0600109 | denotes | ill |
| T30898 | 300-313 | UMLS/C0000769 | denotes | bnormalities |
| T30897 | 300-313 | UMLS/C0000768 | denotes | bnormalities |
| T30896 | 263-268 | UMLS/C1426208 | denotes | OCS1 |
| T30895 | 247-262 | UMLS/C0332281 | denotes | ssociated with |
| T30894 | 672-680 | UMLS/C1705908 | denotes | atients |
| T30893 | 461-469 | UMLS/C1705908 | denotes | atients |
| T30892 | 28-36 | UMLS/C1705908 | denotes | patients |
| T30891 | 818-826 | UMLS/C1552740 | denotes | pecific |
| T30890 | 780-784 | UMLS/C1527132 | denotes | L-6- |
| T30889 | 409-413 | UMLS/C1527132 | denotes | L-6. |
pmc-enju-pas
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31225 | 988-989 | -RRB- | denotes | ] |
| T31224 | 986-988 | CD | denotes | 37 |
| T31223 | 985-986 | -LRB- | denotes | [ |
| T31222 | 978-984 | NN | denotes | models |
| T31221 | 971-977 | NN | denotes | animal |
| T31220 | 968-970 | IN | denotes | in |
| T31219 | 955-967 | VB | denotes | demonstrated |
| T31218 | 950-954 | VB | denotes | been |
| T31217 | 946-949 | VB | denotes | has |
| T31216 | 940-945 | WDT | denotes | which |
| T31215 | 937-939 | IN | denotes | of |
| T31214 | 928-936 | NN | denotes | efficacy |
| T31213 | 924-927 | DT | denotes | the |
| T31212 | 922-923 | -COMMA- | denotes | , |
| T31211 | 918-922 | NN | denotes | gene |
| T31210 | 912-917 | NN | denotes | SOCS3 |
| T31209 | 908-911 | DT | denotes | the |
| T31208 | 905-907 | IN | denotes | of |
| T31207 | 895-904 | NN | denotes | induction |
| T31206 | 891-894 | DT | denotes | the |
| T31205 | 889-890 | -COMMA- | denotes | , |
| T31204 | 882-889 | NN | denotes | example |
| T31203 | 878-881 | IN | denotes | for |
| T31202 | 876-877 | -COLON- | denotes | ; |
| T31201 | 869-876 | VB | denotes | awaited |
| T31200 | 866-868 | VB | denotes | be |
| T31199 | 861-865 | MD | denotes | will |
| T31198 | 850-860 | NN | denotes | activation |
| T31197 | 844-849 | NN | denotes | STAT3 |
| T31196 | 834-843 | VB | denotes | targeting |
| T31195 | 826-833 | NN | denotes | therapy |
| T31194 | 817-825 | JJ | denotes | specific |
| T31193 | 812-816 | RB | denotes | More |
| T31192 | 800-810 | NN | denotes | activation |
| T31191 | 794-799 | NN | denotes | STAT3 |
| T31190 | 779-793 | JJ | denotes | IL-6-dependent |
| T31189 | 776-778 | IN | denotes | of |
| T31188 | 765-775 | NN | denotes | inhibition |
| T31187 | 761-764 | DT | denotes | the |
| T31186 | 753-760 | IN | denotes | through |
| T31185 | 747-752 | NN | denotes | cells |
| T31184 | 745-746 | NN | denotes | T |
| T31183 | 735-744 | VB | denotes | normalize |
| T31182 | 732-734 | TO | denotes | to |
| T31181 | 729-731 | VB | denotes | be |
| T31180 | 725-728 | MD | denotes | may |
| T31179 | 717-724 | NN | denotes | therapy |
| T31178 | 712-716 | DT | denotes | this |
| T31177 | 709-711 | IN | denotes | of |
| T31176 | 701-708 | NN | denotes | effects |
| T31175 | 697-700 | DT | denotes | the |
| T31174 | 694-696 | IN | denotes | of |
| T31173 | 690-693 | CD | denotes | one |
| T31172 | 686-689 | CC | denotes | and |
| T31171 | 684-685 | -COMMA- | denotes | , |
| T31170 | 683-684 | -RRB- | denotes | ] |
| T31169 | 681-683 | CD | denotes | 51 |
| T31168 | 680-681 | -LRB- | denotes | [ |
| T31167 | 671-679 | NN | denotes | patients |
| T31166 | 668-670 | NN | denotes | RA |
| T31165 | 665-667 | IN | denotes | in |
| T31164 | 656-664 | VB | denotes | reported |
| T31163 | 651-655 | VB | denotes | been |
| T31162 | 647-650 | VB | denotes | has |
| T31161 | 638-646 | NN | denotes | antibody |
| T31160 | 629-637 | NN | denotes | receptor |
| T31159 | 619-628 | NN | denotes | anti-IL-6 |
| T31158 | 616-618 | IN | denotes | of |
| T31157 | 607-615 | NN | denotes | efficacy |
| T31156 | 595-606 | JJ | denotes | therapeutic |
| T31155 | 591-594 | DT | denotes | the |
| T31154 | 589-590 | -COMMA- | denotes | , |
| T31153 | 581-589 | NN | denotes | contrary |
| T31152 | 577-580 | DT | denotes | the |
| T31151 | 574-576 | IN | denotes | On |
| T31150 | 567-572 | NN | denotes | cells |
| T31149 | 565-566 | NN | denotes | T |
| T31148 | 555-564 | VB | denotes | including |
| T31147 | 553-554 | -COMMA- | denotes | , |
| T31146 | 548-553 | NN | denotes | cells |
| T31138 | 494-498 | NN | denotes | part |
| T31137 | 491-493 | IN | denotes | in |
| T31136 | 481-490 | VB | denotes | explained |
| T31135 | 478-480 | VB | denotes | be |
| T31134 | 474-477 | MD | denotes | may |
| T31133 | 472-473 | -RRB- | denotes | ] |
| T31132 | 470-472 | CD | denotes | 50 |
| T31131 | 469-470 | -LRB- | denotes | [ |
| T31130 | 460-468 | NN | denotes | patients |
| T31129 | 457-459 | NN | denotes | RA |
| T31128 | 454-456 | IN | denotes | of |
| T31127 | 444-453 | NN | denotes | treatment |
| T31126 | 438-443 | NN | denotes | IL-10 |
| T31125 | 435-437 | IN | denotes | of |
| T31124 | 426-434 | NN | denotes | efficacy |
| T31123 | 418-425 | JJ | denotes | limited |
| T31122 | 414-417 | DT | denotes | The |
| T31121 | 408-412 | NN | denotes | IL-6 |
| T31120 | 405-407 | IN | denotes | of |
| T31119 | 390-404 | NN | denotes | concentrations |
| T31118 | 385-389 | JJ | denotes | high |
| T31117 | 382-384 | TO | denotes | to |
| T31116 | 373-381 | NN | denotes | exposure |
| T31115 | 365-372 | JJ | denotes | chronic |
| T31114 | 359-364 | IN | denotes | after |
| T31113 | 352-358 | RB | denotes | mainly |
| T31112 | 344-351 | VB | denotes | induced |
| T31111 | 341-343 | VB | denotes | be |
| T31110 | 338-340 | TO | denotes | to |
| T31109 | 330-337 | VB | denotes | thought |
| T31108 | 326-329 | VB | denotes | are |
| T31107 | 323-325 | NN | denotes | RA |
| T31106 | 316-322 | JJ | denotes | active |
| T31105 | 313-315 | IN | denotes | in |
| T31104 | 299-312 | NN | denotes | abnormalities |
| T31103 | 293-298 | DT | denotes | These |
| T31102 | 286-291 | NN | denotes | SOCS3 |
| T31101 | 281-285 | IN | denotes | over |
| T31100 | 268-280 | NN | denotes | predominance |
| T31099 | 262-267 | NN | denotes | SOCS1 |
| T31098 | 257-261 | IN | denotes | with |
| T31097 | 246-256 | VB | denotes | associated |
| T31096 | 237-245 | RB | denotes | possibly |
| T31095 | 234-236 | VB | denotes | is |
| T31094 | 224-233 | NN | denotes | signaling |
| T31093 | 218-223 | NN | denotes | STAT3 |
| T31092 | 208-217 | JJ | denotes | defective |
| T31091 | 204-207 | DT | denotes | The |
| T31090 | 192-202 | NN | denotes | activation |
| T31089 | 186-191 | NN | denotes | STAT3 |
| T31088 | 171-185 | JJ | denotes | IL-10-mediated |
| T31087 | 162-170 | JJ | denotes | impaired |
| T31086 | 158-161 | CC | denotes | and |
| T31085 | 142-157 | NN | denotes | phosphorylation |
| T31084 | 136-141 | NN | denotes | STAT3 |
| T31083 | 123-135 | JJ | denotes | constitutive |
| T31082 | 120-122 | TO | denotes | to |
| T31081 | 116-119 | JJ | denotes | due |
| T31080 | 114-115 | -COMMA- | denotes | , |
| T31079 | 104-114 | NN | denotes | production |
| T31078 | 98-103 | NN | denotes | IFN-γ |
| T31077 | 95-97 | IN | denotes | of |
| T31076 | 84-94 | NN | denotes | inhibition |
| T31075 | 78-83 | NN | denotes | IL-10 |
| T31074 | 75-77 | TO | denotes | to |
| T31073 | 64-74 | NN | denotes | resistance |
| T31072 | 58-63 | PRP-DOLLAR- | denotes | their |
| T31071 | 55-57 | IN | denotes | by |
| T31070 | 41-54 | VB | denotes | characterized |
| T31069 | 37-40 | VB | denotes | are |
| T31068 | 28-36 | NN | denotes | patients |
| T31067 | 25-27 | NN | denotes | RA |
| T31066 | 18-24 | JJ | denotes | active |
| T31065 | 13-17 | IN | denotes | from |
| T31064 | 7-12 | NN | denotes | cells |
| T31063 | 5-6 | NN | denotes | T |
| T31062 | 0-4 | JJ | denotes | CD4+ |
| T31145 | 535-547 | JJ | denotes | inflammatory |
| T31144 | 532-534 | IN | denotes | of |
| T31143 | 526-531 | NN | denotes | IL-10 |
| T31142 | 523-525 | TO | denotes | to |
| T31141 | 506-522 | NN | denotes | unresponsiveness |
| T31140 | 502-505 | DT | denotes | the |
| T31139 | 499-501 | IN | denotes | by |
| R16254 | T31064 | T31062 | arg1Of | cells,CD4+ |
| R16255 | T31064 | T31063 | arg1Of | cells,T |
| R16256 | T31064 | T31065 | arg1Of | cells,from |
| R16257 | T31064 | T31069 | arg1Of | cells,are |
| R16258 | T31064 | T31070 | arg2Of | cells,characterized |
| R16259 | T31068 | T31065 | arg2Of | patients,from |
| R16260 | T31068 | T31066 | arg1Of | patients,active |
| R16261 | T31068 | T31067 | arg1Of | patients,RA |
| R16262 | T31070 | T31069 | arg2Of | characterized,are |
| R16263 | T31073 | T31070 | arg1Of | resistance,characterized |
| R16264 | T31073 | T31071 | arg2Of | resistance,by |
| R16265 | T31073 | T31072 | arg1Of | resistance,their |
| R16266 | T31073 | T31074 | arg1Of | resistance,to |
| R16267 | T31076 | T31074 | arg2Of | inhibition,to |
| R16268 | T31076 | T31075 | arg1Of | inhibition,IL-10 |
| R16269 | T31076 | T31077 | arg1Of | inhibition,of |
| R16270 | T31076 | T31080 | arg1Of | inhibition,"," |
| R16271 | T31076 | T31082 | arg1Of | inhibition,to |
| R16272 | T31079 | T31077 | arg2Of | production,of |
| R16273 | T31079 | T31078 | arg1Of | production,IFN-γ |
| R16274 | T31082 | T31081 | arg1Of | to,due |
| R16275 | T31085 | T31083 | arg1Of | phosphorylation,constitutive |
| R16276 | T31085 | T31084 | arg1Of | phosphorylation,STAT3 |
| R16277 | T31085 | T31086 | arg1Of | phosphorylation,and |
| R16278 | T31086 | T31082 | arg2Of | and,to |
| R16279 | T31090 | T31086 | arg2Of | activation,and |
| R16280 | T31090 | T31087 | arg1Of | activation,impaired |
| R16281 | T31090 | T31088 | arg1Of | activation,IL-10-mediated |
| R16282 | T31090 | T31089 | arg1Of | activation,STAT3 |
| R16283 | T31094 | T31091 | arg1Of | signaling,The |
| R16284 | T31094 | T31092 | arg1Of | signaling,defective |
| R16285 | T31094 | T31093 | arg1Of | signaling,STAT3 |
| R16286 | T31094 | T31095 | arg1Of | signaling,is |
| R16287 | T31094 | T31097 | arg2Of | signaling,associated |
| R16288 | T31097 | T31095 | arg2Of | associated,is |
| R16289 | T31097 | T31096 | arg1Of | associated,possibly |
| R16290 | T31097 | T31098 | arg1Of | associated,with |
| R16291 | T31100 | T31098 | arg2Of | predominance,with |
| R16292 | T31100 | T31099 | arg1Of | predominance,SOCS1 |
| R16293 | T31100 | T31101 | arg1Of | predominance,over |
| R16294 | T31102 | T31101 | arg2Of | SOCS3,over |
| R16295 | T31104 | T31103 | arg1Of | abnormalities,These |
| R16296 | T31104 | T31105 | arg1Of | abnormalities,in |
| R16297 | T31104 | T31108 | arg1Of | abnormalities,are |
| R16298 | T31104 | T31109 | arg2Of | abnormalities,thought |
| R16299 | T31104 | T31111 | arg1Of | abnormalities,be |
| R16300 | T31104 | T31112 | arg2Of | abnormalities,induced |
| R16301 | T31107 | T31105 | arg2Of | RA,in |
| R16302 | T31107 | T31106 | arg1Of | RA,active |
| R16303 | T31109 | T31108 | arg2Of | thought,are |
| R16304 | T31112 | T31109 | arg3Of | induced,thought |
| R16305 | T31112 | T31110 | arg1Of | induced,to |
| R16306 | T31112 | T31111 | arg2Of | induced,be |
| R16307 | T31112 | T31114 | arg1Of | induced,after |
| R16308 | T31114 | T31113 | arg1Of | after,mainly |
| R16309 | T31116 | T31114 | arg2Of | exposure,after |
| R16310 | T31116 | T31115 | arg1Of | exposure,chronic |
| R16311 | T31116 | T31117 | arg1Of | exposure,to |
| R16312 | T31119 | T31117 | arg2Of | concentrations,to |
| R16313 | T31119 | T31118 | arg1Of | concentrations,high |
| R16314 | T31119 | T31120 | arg1Of | concentrations,of |
| R16315 | T31121 | T31120 | arg2Of | IL-6,of |
| R16316 | T31124 | T31122 | arg1Of | efficacy,The |
| R16317 | T31124 | T31123 | arg1Of | efficacy,limited |
| R16318 | T31124 | T31125 | arg1Of | efficacy,of |
| R16319 | T31124 | T31134 | arg1Of | efficacy,may |
| R16320 | T31124 | T31135 | arg1Of | efficacy,be |
| R16321 | T31124 | T31136 | arg2Of | efficacy,explained |
| R16322 | T31127 | T31125 | arg2Of | treatment,of |
| R16323 | T31127 | T31126 | arg1Of | treatment,IL-10 |
| R16324 | T31127 | T31128 | arg1Of | treatment,of |
| R16325 | T31127 | T31131 | arg1Of | treatment,[ |
| R16326 | T31130 | T31128 | arg2Of | patients,of |
| R16327 | T31130 | T31129 | arg1Of | patients,RA |
| R16328 | T31132 | T31131 | arg2Of | 50,[ |
| R16329 | T31133 | T31131 | arg3Of | ],[ |
| R16330 | T31136 | T31134 | arg2Of | explained,may |
| R16331 | T31136 | T31135 | arg2Of | explained,be |
| R16332 | T31136 | T31137 | arg1Of | explained,in |
| R16333 | T31138 | T31137 | arg2Of | part,in |
| R16334 | T31141 | T31136 | arg1Of | unresponsiveness,explained |
| R16335 | T31141 | T31139 | arg2Of | unresponsiveness,by |
| R16336 | T31141 | T31140 | arg1Of | unresponsiveness,the |
| R16337 | T31141 | T31142 | arg1Of | unresponsiveness,to |
| R16338 | T31143 | T31142 | arg2Of | IL-10,to |
| R16339 | T31143 | T31144 | arg1Of | IL-10,of |
| R16340 | T31146 | T31144 | arg2Of | cells,of |
| R16341 | T31146 | T31145 | arg1Of | cells,inflammatory |
| R16342 | T31146 | T31147 | arg1Of | cells,"," |
| R16343 | T31146 | T31148 | arg1Of | cells,including |
| R16344 | T31150 | T31148 | arg2Of | cells,including |
| R16345 | T31150 | T31149 | arg1Of | cells,T |
| R16346 | T31153 | T31151 | arg2Of | contrary,On |
| R16347 | T31153 | T31152 | arg1Of | contrary,the |
| R16348 | T31157 | T31155 | arg1Of | efficacy,the |
| R16349 | T31157 | T31156 | arg1Of | efficacy,therapeutic |
| R16350 | T31157 | T31158 | arg1Of | efficacy,of |
| R16351 | T31157 | T31162 | arg1Of | efficacy,has |
| R16352 | T31157 | T31163 | arg1Of | efficacy,been |
| R16353 | T31157 | T31164 | arg2Of | efficacy,reported |
| R16354 | T31161 | T31158 | arg2Of | antibody,of |
| R16355 | T31161 | T31159 | arg1Of | antibody,anti-IL-6 |
| R16356 | T31161 | T31160 | arg1Of | antibody,receptor |
| R16357 | T31164 | T31162 | arg2Of | reported,has |
| R16358 | T31164 | T31163 | arg2Of | reported,been |
| R16359 | T31164 | T31165 | arg1Of | reported,in |
| R16360 | T31164 | T31172 | arg1Of | reported,and |
| R16361 | T31167 | T31165 | arg2Of | patients,in |
| R16362 | T31167 | T31166 | arg1Of | patients,RA |
| R16363 | T31167 | T31168 | arg1Of | patients,[ |
| R16364 | T31169 | T31168 | arg2Of | 51,[ |
| R16365 | T31170 | T31168 | arg3Of | ],[ |
| R16366 | T31172 | T31151 | arg1Of | and,On |
| R16367 | T31172 | T31154 | arg1Of | and,"," |
| R16368 | T31172 | T31171 | arg1Of | and,"," |
| R16369 | T31173 | T31174 | arg1Of | one,of |
| R16370 | T31173 | T31180 | arg1Of | one,may |
| R16371 | T31173 | T31181 | arg1Of | one,be |
| R16372 | T31176 | T31174 | arg2Of | effects,of |
| R16373 | T31176 | T31175 | arg1Of | effects,the |
| R16374 | T31176 | T31177 | arg1Of | effects,of |
| R16375 | T31179 | T31177 | arg2Of | therapy,of |
| R16376 | T31179 | T31178 | arg1Of | therapy,this |
| R16377 | T31181 | T31172 | arg2Of | be,and |
| R16378 | T31181 | T31180 | arg2Of | be,may |
| R16379 | T31183 | T31181 | arg2Of | normalize,be |
| R16380 | T31183 | T31182 | arg1Of | normalize,to |
| R16381 | T31183 | T31186 | arg1Of | normalize,through |
| R16382 | T31185 | T31183 | arg2Of | cells,normalize |
| R16383 | T31185 | T31184 | arg1Of | cells,T |
| R16384 | T31188 | T31186 | arg2Of | inhibition,through |
| R16385 | T31188 | T31187 | arg1Of | inhibition,the |
| R16386 | T31188 | T31189 | arg1Of | inhibition,of |
| R16387 | T31192 | T31189 | arg2Of | activation,of |
| R16388 | T31192 | T31190 | arg1Of | activation,IL-6-dependent |
| R16389 | T31192 | T31191 | arg1Of | activation,STAT3 |
| R16390 | T31194 | T31193 | arg1Of | specific,More |
| R16391 | T31195 | T31194 | arg1Of | therapy,specific |
| R16392 | T31195 | T31196 | arg1Of | therapy,targeting |
| R16393 | T31195 | T31199 | arg1Of | therapy,will |
| R16394 | T31195 | T31200 | arg1Of | therapy,be |
| R16395 | T31195 | T31201 | arg2Of | therapy,awaited |
| R16396 | T31198 | T31196 | arg2Of | activation,targeting |
| R16397 | T31198 | T31197 | arg1Of | activation,STAT3 |
| R16398 | T31201 | T31199 | arg2Of | awaited,will |
| R16399 | T31201 | T31200 | arg2Of | awaited,be |
| R16400 | T31201 | T31202 | arg1Of | awaited,; |
| R16401 | T31201 | T31203 | arg1Of | awaited,for |
| R16402 | T31204 | T31203 | arg2Of | example,for |
| R16403 | T31204 | T31205 | arg1Of | example,"," |
| R16404 | T31204 | T31215 | arg2Of | example,of |
| R16405 | T31204 | T31216 | arg1Of | example,which |
| R16406 | T31207 | T31205 | arg2Of | induction,"," |
| R16407 | T31207 | T31206 | arg1Of | induction,the |
| R16408 | T31207 | T31208 | arg1Of | induction,of |
| R16409 | T31211 | T31208 | arg2Of | gene,of |
| R16410 | T31211 | T31209 | arg1Of | gene,the |
| R16411 | T31211 | T31210 | arg1Of | gene,SOCS3 |
| R16412 | T31214 | T31213 | arg1Of | efficacy,the |
| R16413 | T31214 | T31215 | arg1Of | efficacy,of |
| R16414 | T31214 | T31217 | arg1Of | efficacy,has |
| R16415 | T31214 | T31218 | arg1Of | efficacy,been |
| R16416 | T31214 | T31219 | arg2Of | efficacy,demonstrated |
| R16417 | T31219 | T31212 | arg1Of | demonstrated,"," |
| R16418 | T31219 | T31217 | arg2Of | demonstrated,has |
| R16419 | T31219 | T31218 | arg2Of | demonstrated,been |
| R16420 | T31219 | T31220 | arg1Of | demonstrated,in |
| R16421 | T31219 | T31223 | arg1Of | demonstrated,[ |
| R16422 | T31222 | T31220 | arg2Of | models,in |
| R16423 | T31222 | T31221 | arg1Of | models,animal |
| R16424 | T31224 | T31223 | arg2Of | 37,[ |
| R16425 | T31225 | T31223 | arg3Of | ],[ |
bionlp-st-ge-2016-test-proteins
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30991 | 912-917 | Protein | denotes | SOCS3 |
| T30990 | 844-849 | Protein | denotes | STAT3 |
| T30989 | 794-799 | Protein | denotes | STAT3 |
| T30988 | 779-783 | Protein | denotes | IL-6 |
| T30987 | 624-637 | Protein | denotes | IL-6 receptor |
| T30986 | 526-531 | Protein | denotes | IL-10 |
| T30985 | 438-443 | Protein | denotes | IL-10 |
| T30984 | 408-412 | Protein | denotes | IL-6 |
| T30983 | 286-291 | Protein | denotes | SOCS3 |
| T30982 | 262-267 | Protein | denotes | SOCS1 |
| T30981 | 218-223 | Protein | denotes | STAT3 |
| T30980 | 186-191 | Protein | denotes | STAT3 |
| T30979 | 171-176 | Protein | denotes | IL-10 |
| T30978 | 136-141 | Protein | denotes | STAT3 |
| T30977 | 98-103 | Protein | denotes | IFN-γ |
| T30976 | 78-83 | Protein | denotes | IL-10 |
| T30975 | 1-3 | Protein | denotes | D4 |
bionlp-st-ge-2016-uniprot
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31022 | 779-783 | http://www.uniprot.org/uniprot/P05231 | denotes | IL-6 |
| T31021 | 624-628 | http://www.uniprot.org/uniprot/P05231 | denotes | IL-6 |
| T31020 | 408-412 | http://www.uniprot.org/uniprot/P05231 | denotes | IL-6 |
| T31019 | 262-267 | http://www.uniprot.org/uniprot/O15524 | denotes | SOCS1 |
| T31018 | 844-849 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T31017 | 794-799 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T31016 | 218-223 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T31015 | 186-191 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T31014 | 136-141 | http://www.uniprot.org/uniprot/P40763 | denotes | STAT3 |
| T31013 | 98-103 | http://www.uniprot.org/uniprot/P01579 | denotes | IFN-γ |
| T31012 | 526-531 | http://www.uniprot.org/uniprot/P22301 | denotes | IL-10 |
| T31011 | 438-443 | http://www.uniprot.org/uniprot/P22301 | denotes | IL-10 |
| T31010 | 171-176 | http://www.uniprot.org/uniprot/P22301 | denotes | IL-10 |
| T31009 | 78-83 | http://www.uniprot.org/uniprot/P22301 | denotes | IL-10 |
| T31008 | 0-3 | http://www.uniprot.org/uniprot/P01730 | denotes | CD4 |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30941 | 624-637 | http://purl.obolibrary.org/obo/GO_0004915 | denotes | IL-6 receptor |
| T30940 | 224-233 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
| T30939 | 142-157 | http://purl.obolibrary.org/obo/GO_0016310 | denotes | phosphorylation |
| T30938 | 84-103 | http://purl.obolibrary.org/obo/GO_1902714 | denotes | inhibition of IFN-γ |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31004 | 747-752 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T31003 | 567-572 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T31002 | 548-553 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T31001 | 7-12 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T31007 | 638-646 | http://purl.obolibrary.org/obo/GO_0042571 | denotes | antibody |
| T31006 | 638-646 | http://purl.obolibrary.org/obo/GO_0019815 | denotes | antibody |
| T31005 | 624-637 | http://purl.obolibrary.org/obo/GO_0005896 | denotes | IL-6 receptor |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31000 | 638-646 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T30999 | 624-637 | http://purl.obolibrary.org/obo/GO_0004915 | denotes | IL-6 receptor |
| T30998 | 779-783 | http://purl.obolibrary.org/obo/GO_0005138 | denotes | IL-6 |
| T30997 | 624-628 | http://purl.obolibrary.org/obo/GO_0005138 | denotes | IL-6 |
| T30996 | 408-412 | http://purl.obolibrary.org/obo/GO_0005138 | denotes | IL-6 |
| T30995 | 526-531 | http://purl.obolibrary.org/obo/GO_0005141 | denotes | IL-10 |
| T30994 | 438-443 | http://purl.obolibrary.org/obo/GO_0005141 | denotes | IL-10 |
| T30993 | 171-176 | http://purl.obolibrary.org/obo/GO_0005141 | denotes | IL-10 |
| T30992 | 78-83 | http://purl.obolibrary.org/obo/GO_0005141 | denotes | IL-10 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30937 | 812-990 | Sentence | denotes | More specific therapy targeting STAT3 activation will be awaited; for example, the induction of the SOCS3 gene, the efficacy of which has been demonstrated in animal models [37]. |
| T30936 | 574-811 | Sentence | denotes | On the contrary, the therapeutic efficacy of anti-IL-6 receptor antibody has been reported in RA patients [51], and one of the effects of this therapy may be to normalize T cells through the inhibition of IL-6-dependent STAT3 activation. |
| T30935 | 414-573 | Sentence | denotes | The limited efficacy of IL-10 treatment of RA patients [50] may be explained in part by the unresponsiveness to IL-10 of inflammatory cells, including T cells. |
| T30934 | 293-413 | Sentence | denotes | These abnormalities in active RA are thought to be induced mainly after chronic exposure to high concentrations of IL-6. |
| T30933 | 204-292 | Sentence | denotes | The defective STAT3 signaling is possibly associated with SOCS1 predominance over SOCS3. |
| T30932 | 0-203 | Sentence | denotes | CD4+ T cells from active RA patients are characterized by their resistance to IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation and impaired IL-10-mediated STAT3 activation. |
| T201 | 0-203 | Sentence | denotes | CD4+ T cells from active RA patients are characterized by their resistance to IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation and impaired IL-10-mediated STAT3 activation. |
| T202 | 204-292 | Sentence | denotes | The defective STAT3 signaling is possibly associated with SOCS1 predominance over SOCS3. |
| T203 | 293-413 | Sentence | denotes | These abnormalities in active RA are thought to be induced mainly after chronic exposure to high concentrations of IL-6. |
| T204 | 414-573 | Sentence | denotes | The limited efficacy of IL-10 treatment of RA patients [50] may be explained in part by the unresponsiveness to IL-10 of inflammatory cells, including T cells. |
| T205 | 574-811 | Sentence | denotes | On the contrary, the therapeutic efficacy of anti-IL-6 receptor antibody has been reported in RA patients [51], and one of the effects of this therapy may be to normalize T cells through the inhibition of IL-6-dependent STAT3 activation. |
| T206 | 812-990 | Sentence | denotes | More specific therapy targeting STAT3 activation will be awaited; for example, the induction of the SOCS3 gene, the efficacy of which has been demonstrated in animal models [37]. |
simple1
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31061 | 912-917 | Protein | denotes | SOCS3 |
| T31060 | 844-849 | Protein | denotes | STAT3 |
| T31059 | 794-799 | Protein | denotes | STAT3 |
| T31058 | 779-783 | Protein | denotes | IL-6 |
| T31057 | 624-637 | Protein | denotes | IL-6 receptor |
| T31056 | 526-531 | Protein | denotes | IL-10 |
| T31055 | 438-443 | Protein | denotes | IL-10 |
| T31054 | 408-412 | Protein | denotes | IL-6 |
| T31053 | 286-291 | Protein | denotes | SOCS3 |
| T31052 | 262-267 | Protein | denotes | SOCS1 |
| T31051 | 218-223 | Protein | denotes | STAT3 |
| T31050 | 186-191 | Protein | denotes | STAT3 |
| T31049 | 171-176 | Protein | denotes | IL-10 |
| T31048 | 136-141 | Protein | denotes | STAT3 |
| T31047 | 98-103 | Protein | denotes | IFN-γ |
| T31046 | 78-83 | Protein | denotes | IL-10 |
| T31045 | 1-3 | Protein | denotes | D4 |
BioNLP16_DUT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31567 | 844-849 | Protein | denotes | STAT3 |
| T31566 | 794-799 | Protein | denotes | STAT3 |
| T31565 | 779-783 | Protein | denotes | IL-6 |
| T31578 | 895-904 | Positive_regulation | denotes | induction |
| T31577 | 834-843 | Regulation | denotes | targeting |
| T31576 | 850-860 | Positive_regulation | denotes | activation |
| T31575 | 800-810 | Positive_regulation | denotes | activation |
| T31574 | 765-775 | Negative_regulation | denotes | inhibition |
| T31573 | 192-202 | Positive_regulation | denotes | activation |
| T31572 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T31571 | 104-114 | Gene_expression | denotes | production |
| T31570 | 162-170 | Negative_regulation | denotes | impaired |
| T31569 | 84-94 | Negative_regulation | denotes | inhibition |
| T31568 | 912-917 | Protein | denotes | SOCS3 |
| T31564 | 624-637 | Protein | denotes | IL-6 receptor |
| T31563 | 526-531 | Protein | denotes | IL-10 |
| T31562 | 438-443 | Protein | denotes | IL-10 |
| T31561 | 408-412 | Protein | denotes | IL-6 |
| T31560 | 286-291 | Protein | denotes | SOCS3 |
| T31559 | 262-267 | Protein | denotes | SOCS1 |
| T31558 | 218-223 | Protein | denotes | STAT3 |
| T31557 | 186-191 | Protein | denotes | STAT3 |
| T31556 | 171-176 | Protein | denotes | IL-10 |
| T31555 | 136-141 | Protein | denotes | STAT3 |
| T31554 | 98-103 | Protein | denotes | IFN-γ |
| T31553 | 78-83 | Protein | denotes | IL-10 |
| T31552 | 1-3 | Protein | denotes | D4 |
| R16659 | T31553 | T31569 | themeOf | IL-10,inhibition |
| R16660 | T31554 | T31571 | themeOf | IFN-γ,production |
| R16661 | T31555 | T31572 | themeOf | STAT3,phosphorylation |
| R16662 | T31557 | T31573 | themeOf | STAT3,activation |
| R16663 | T31566 | T31575 | themeOf | STAT3,activation |
| R16664 | T31567 | T31576 | themeOf | STAT3,activation |
| R16665 | T31568 | T31578 | themeOf | SOCS3,induction |
| R16666 | T31571 | T31569 | themeOf | production,inhibition |
| R16667 | T31573 | T31570 | themeOf | activation,impaired |
| R16668 | T31575 | T31574 | themeOf | activation,inhibition |
| R16669 | T31576 | T31577 | themeOf | activation,targeting |
BioNLP16_Messiy
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31255 | 895-904 | Positive_regulation | denotes | induction |
| T31254 | 834-843 | Positive_regulation | denotes | targeting |
| T31253 | 850-860 | Positive_regulation | denotes | activation |
| T31252 | 800-810 | Positive_regulation | denotes | activation |
| T31251 | 765-775 | Negative_regulation | denotes | inhibition |
| T31250 | 784-793 | Regulation | denotes | dependent |
| T31249 | 177-185 | Positive_regulation | denotes | mediated |
| T31248 | 192-202 | Positive_regulation | denotes | activation |
| T31247 | 104-114 | Gene_expression | denotes | production |
| T31246 | 162-170 | Negative_regulation | denotes | impaired |
| T31245 | 84-94 | Negative_regulation | denotes | inhibition |
| T31244 | 64-74 | Positive_regulation | denotes | resistance |
| T31243 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T31242 | 912-917 | Protein | denotes | SOCS3 |
| T31241 | 844-849 | Protein | denotes | STAT3 |
| T31240 | 794-799 | Protein | denotes | STAT3 |
| T31239 | 779-783 | Protein | denotes | IL-6 |
| T31238 | 624-637 | Protein | denotes | IL-6 receptor |
| T31237 | 526-531 | Protein | denotes | IL-10 |
| T31236 | 438-443 | Protein | denotes | IL-10 |
| T31235 | 408-412 | Protein | denotes | IL-6 |
| T31234 | 286-291 | Protein | denotes | SOCS3 |
| T31233 | 262-267 | Protein | denotes | SOCS1 |
| T31232 | 218-223 | Protein | denotes | STAT3 |
| T31231 | 186-191 | Protein | denotes | STAT3 |
| T31230 | 171-176 | Protein | denotes | IL-10 |
| T31229 | 136-141 | Protein | denotes | STAT3 |
| T31228 | 98-103 | Protein | denotes | IFN-γ |
| T31227 | 78-83 | Protein | denotes | IL-10 |
| T31226 | 1-3 | Protein | denotes | D4 |
| R16426 | T31227 | T31245 | themeOf | IL-10,inhibition |
| R16427 | T31228 | T31247 | themeOf | IFN-γ,production |
| R16428 | T31229 | T31243 | themeOf | STAT3,phosphorylation |
| R16429 | T31231 | T31248 | themeOf | STAT3,activation |
| R16430 | T31240 | T31252 | themeOf | STAT3,activation |
| R16431 | T31241 | T31253 | themeOf | STAT3,activation |
| R16432 | T31242 | T31255 | themeOf | SOCS3,induction |
| R16433 | T31245 | T31244 | themeOf | inhibition,resistance |
| R16434 | T31245 | T31244 | themeOf | inhibition,resistance |
| R16435 | T31247 | T31245 | themeOf | production,inhibition |
| R16436 | T31248 | T31246 | themeOf | activation,impaired |
| R16437 | T31248 | T31249 | themeOf | activation,mediated |
| R16438 | T31252 | T31251 | themeOf | activation,inhibition |
| R16439 | T31252 | T31250 | themeOf | activation,dependent |
| R16440 | T31253 | T31254 | themeOf | activation,targeting |
DLUT931
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31453 | 834-843 | Positive_regulation | denotes | targeting |
| T31452 | 895-904 | Positive_regulation | denotes | induction |
| T31451 | 850-860 | Positive_regulation | denotes | activation |
| T31450 | 784-793 | Regulation | denotes | dependent |
| T31449 | 765-775 | Negative_regulation | denotes | inhibition |
| T31448 | 800-810 | Positive_regulation | denotes | activation |
| T31447 | 208-217 | Negative_regulation | denotes | defective |
| T31446 | 123-135 | Positive_regulation | denotes | constitutive |
| T31445 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T31444 | 104-114 | Gene_expression | denotes | production |
| T31443 | 912-917 | Protein | denotes | SOCS3 |
| T31442 | 844-849 | Protein | denotes | STAT3 |
| T31441 | 794-799 | Protein | denotes | STAT3 |
| T31440 | 779-783 | Protein | denotes | IL-6 |
| T31439 | 624-637 | Protein | denotes | IL-6 receptor |
| T31438 | 526-531 | Protein | denotes | IL-10 |
| T31437 | 438-443 | Protein | denotes | IL-10 |
| T31436 | 408-412 | Protein | denotes | IL-6 |
| T31435 | 286-291 | Protein | denotes | SOCS3 |
| T31434 | 262-267 | Protein | denotes | SOCS1 |
| T31433 | 218-223 | Protein | denotes | STAT3 |
| T31432 | 186-191 | Protein | denotes | STAT3 |
| T31431 | 171-176 | Protein | denotes | IL-10 |
| T31430 | 136-141 | Protein | denotes | STAT3 |
| T31429 | 98-103 | Protein | denotes | IFN-γ |
| T31428 | 78-83 | Protein | denotes | IL-10 |
| T31427 | 1-3 | Protein | denotes | D4 |
| R16612 | T31429 | T31444 | themeOf | IFN-γ,production |
| R16613 | T31430 | T31445 | themeOf | STAT3,phosphorylation |
| R16614 | T31433 | T31447 | themeOf | STAT3,defective |
| R16615 | T31440 | T31450 | causeOf | IL-6,dependent |
| R16616 | T31441 | T31448 | themeOf | STAT3,activation |
| R16617 | T31442 | T31451 | themeOf | STAT3,activation |
| R16618 | T31443 | T31452 | themeOf | SOCS3,induction |
| R16619 | T31445 | T31446 | themeOf | phosphorylation,constitutive |
| R16620 | T31448 | T31449 | themeOf | activation,inhibition |
| R16621 | T31448 | T31450 | themeOf | activation,dependent |
| R16622 | T31451 | T31453 | themeOf | activation,targeting |
bionlp-st-ge-2016-test-ihmc
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31551 | 95-115 | Gene_expression | denotes | of IFN-γ production, |
| T31550 | 204-233 | Positive_regulation | denotes | The defective STAT3 signaling |
| T31549 | 171-202 | Regulation | denotes | IL-10-mediated STAT3 activation |
| T31548 | 78-157 | Negative_regulation | denotes | IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation |
| T31547 | 123-157 | Phosphorylation | denotes | constitutive STAT3 phosphorylation |
| T31546 | 891-923 | Positive_regulation | denotes | the induction of the SOCS3 gene, |
| T31545 | 891-923 | Gene_expression | denotes | the induction of the SOCS3 gene, |
| T31544 | 171-202 | Positive_regulation | denotes | IL-10-mediated STAT3 activation |
| T31543 | 776-810 | Regulation | denotes | of IL-6-dependent STAT3 activation |
| T31542 | 761-810 | Negative_regulation | denotes | the inhibition of IL-6-dependent STAT3 activation |
| T31541 | 776-810 | Positive_regulation | denotes | of IL-6-dependent STAT3 activation |
| T31540 | 844-860 | Positive_regulation | denotes | STAT3 activation |
| T31539 | 316-325 | Protein | denotes | active RA |
| T31538 | 535-554 | Entity | denotes | inflammatory cells, |
| T31537 | 526-554 | Protein | denotes | IL-10 of inflammatory cells, |
| T31536 | 218-223 | Protein | denotes | STAT3 |
| T31535 | 171-185 | Protein | denotes | IL-10-mediated |
| T31534 | 286-291 | Protein | denotes | SOCS3 |
| T31533 | 0-12 | Entity | denotes | CD4+ T cells |
| T31532 | 565-572 | Entity | denotes | T cells |
| T31531 | 136-141 | Protein | denotes | STAT3 |
| T31530 | 78-83 | Protein | denotes | IL-10 |
| T31529 | 745-752 | Entity | denotes | T cells |
| T31528 | 844-849 | Protein | denotes | STAT3 |
| T31527 | 779-793 | Protein | denotes | IL-6-dependent |
| T31526 | 457-459 | Protein | denotes | RA |
| T31525 | 186-191 | Protein | denotes | STAT3 |
| T31524 | 905-922 | Protein | denotes | of the SOCS3 gene |
| T31523 | 912-917 | Protein | denotes | SOCS3 |
| T31522 | 405-412 | Protein | denotes | of IL-6 |
| T31521 | 435-443 | Protein | denotes | of IL-10 |
| T31520 | 25-27 | Protein | denotes | RA |
| T31519 | 262-267 | Protein | denotes | SOCS1 |
| T31518 | 98-103 | Protein | denotes | IFN-γ |
| T31517 | 794-799 | Protein | denotes | STAT3 |
| T31516 | 668-670 | Protein | denotes | RA |
| R16644 | T31517 | T31541 | themeOf | STAT3,of IL-6-dependent STAT3 activation |
| R16646 | T31524 | T31545 | themeOf | of the SOCS3 gene,"the induction of the SOCS3 gene," |
| R16647 | T31524 | T31546 | themeOf | of the SOCS3 gene,"the induction of the SOCS3 gene," |
| R16648 | T31525 | T31544 | themeOf | STAT3,IL-10-mediated STAT3 activation |
| R16649 | T31527 | T31543 | causeOf | IL-6-dependent,of IL-6-dependent STAT3 activation |
| R16650 | T31528 | T31540 | themeOf | STAT3,STAT3 activation |
| R16651 | T31530 | T31548 | causeOf | IL-10,"IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation" |
| R16652 | T31531 | T31547 | themeOf | STAT3,constitutive STAT3 phosphorylation |
| R16655 | T31541 | T31542 | themeOf | of IL-6-dependent STAT3 activation,the inhibition of IL-6-dependent STAT3 activation |
| R16656 | T31541 | T31543 | themeOf | of IL-6-dependent STAT3 activation,of IL-6-dependent STAT3 activation |
| R16658 | T31551 | T31548 | themeOf | "of IFN-γ production,","IL-10 inhibition of IFN-γ production, due to constitutive STAT3 phosphorylation" |
| R16645 | T31518 | T31551 | themeOf | IFN-γ,"of IFN-γ production," |
| R16653 | T31535 | T31549 | causeOf | IL-10-mediated,IL-10-mediated STAT3 activation |
| R16654 | T31536 | T31550 | causeOf | STAT3,The defective STAT3 signaling |
| R16657 | T31544 | T31549 | themeOf | IL-10-mediated STAT3 activation,IL-10-mediated STAT3 activation |
bionlp-st-ge-2016-spacy-parsed
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31426 | 989-990 | . | denotes | . |
| T31425 | 988-989 | NNP | denotes | ] |
| T31424 | 986-988 | CD | denotes | 37 |
| T31423 | 985-986 | NNP | denotes | [ |
| T31422 | 978-984 | NNS | denotes | models |
| T31421 | 971-977 | NN | denotes | animal |
| T31420 | 968-970 | IN | denotes | in |
| T31419 | 955-967 | VBN | denotes | demonstrated |
| T31418 | 950-954 | VBN | denotes | been |
| T31417 | 946-949 | VBZ | denotes | has |
| T31416 | 940-945 | WDT | denotes | which |
| T31415 | 937-939 | IN | denotes | of |
| T31414 | 928-936 | NN | denotes | efficacy |
| T31413 | 924-927 | DT | denotes | the |
| T31412 | 922-923 | , | denotes | , |
| T31411 | 918-922 | NN | denotes | gene |
| T31410 | 912-917 | CD | denotes | SOCS3 |
| T31409 | 908-911 | DT | denotes | the |
| T31408 | 905-907 | IN | denotes | of |
| T31407 | 895-904 | NN | denotes | induction |
| T31406 | 891-894 | DT | denotes | the |
| T31405 | 889-890 | , | denotes | , |
| T31404 | 882-889 | NN | denotes | example |
| T31403 | 878-881 | IN | denotes | for |
| T31402 | 876-877 | : | denotes | ; |
| T31401 | 869-876 | VBN | denotes | awaited |
| T31400 | 866-868 | VB | denotes | be |
| T31399 | 861-865 | MD | denotes | will |
| T31398 | 850-860 | NN | denotes | activation |
| T31397 | 844-849 | CD | denotes | STAT3 |
| T31396 | 834-843 | VBG | denotes | targeting |
| T31395 | 826-833 | NN | denotes | therapy |
| T31394 | 817-825 | JJ | denotes | specific |
| T31393 | 812-816 | RBR | denotes | More |
| T31392 | 810-811 | . | denotes | . |
| T31391 | 800-810 | NN | denotes | activation |
| T31390 | 794-799 | CD | denotes | STAT3 |
| T31389 | 779-793 | JJ | denotes | IL-6-dependent |
| T31388 | 776-778 | IN | denotes | of |
| T31387 | 765-775 | NN | denotes | inhibition |
| T31386 | 761-764 | DT | denotes | the |
| T31385 | 753-760 | IN | denotes | through |
| T31384 | 747-752 | NNS | denotes | cells |
| T31383 | 745-746 | NNP | denotes | T |
| T31382 | 735-744 | VB | denotes | normalize |
| T31381 | 732-734 | TO | denotes | to |
| T31380 | 729-731 | VB | denotes | be |
| T31379 | 725-728 | MD | denotes | may |
| T31378 | 717-724 | NN | denotes | therapy |
| T31377 | 712-716 | DT | denotes | this |
| T31376 | 709-711 | IN | denotes | of |
| T31375 | 701-708 | NNS | denotes | effects |
| T31374 | 697-700 | DT | denotes | the |
| T31373 | 694-696 | IN | denotes | of |
| T31372 | 690-693 | CD | denotes | one |
| T31371 | 686-689 | CC | denotes | and |
| T31361 | 647-650 | VBZ | denotes | has |
| T31360 | 638-646 | NN | denotes | antibody |
| T31359 | 629-637 | NN | denotes | receptor |
| T31358 | 619-628 | NN | denotes | anti-IL-6 |
| T31357 | 616-618 | IN | denotes | of |
| T31356 | 607-615 | NN | denotes | efficacy |
| T31355 | 595-606 | JJ | denotes | therapeutic |
| T31354 | 591-594 | DT | denotes | the |
| T31353 | 589-590 | , | denotes | , |
| T31352 | 581-589 | NN | denotes | contrary |
| T31351 | 577-580 | DT | denotes | the |
| T31350 | 574-576 | IN | denotes | On |
| T31349 | 572-573 | . | denotes | . |
| T31348 | 567-572 | NNS | denotes | cells |
| T31347 | 565-566 | NNP | denotes | T |
| T31346 | 555-564 | VBG | denotes | including |
| T31345 | 553-554 | , | denotes | , |
| T31344 | 548-553 | NNS | denotes | cells |
| T31343 | 535-547 | JJ | denotes | inflammatory |
| T31342 | 532-534 | IN | denotes | of |
| T31341 | 526-531 | NNP | denotes | IL-10 |
| T31340 | 523-525 | TO | denotes | to |
| T31339 | 506-522 | NN | denotes | unresponsiveness |
| T31338 | 502-505 | DT | denotes | the |
| T31337 | 499-501 | IN | denotes | by |
| T31336 | 494-498 | NN | denotes | part |
| T31335 | 491-493 | IN | denotes | in |
| T31334 | 481-490 | VBN | denotes | explained |
| T31333 | 478-480 | VB | denotes | be |
| T31332 | 474-477 | MD | denotes | may |
| T31331 | 472-473 | NNP | denotes | ] |
| T31330 | 470-472 | CD | denotes | 50 |
| T31329 | 469-470 | NNP | denotes | [ |
| T31328 | 460-468 | NNS | denotes | patients |
| T31327 | 457-459 | NNP | denotes | RA |
| T31326 | 454-456 | IN | denotes | of |
| T31325 | 444-453 | NN | denotes | treatment |
| T31324 | 438-443 | JJ | denotes | IL-10 |
| T31323 | 435-437 | IN | denotes | of |
| T31322 | 426-434 | NN | denotes | efficacy |
| T31321 | 418-425 | JJ | denotes | limited |
| T31320 | 414-417 | DT | denotes | The |
| T31319 | 412-413 | . | denotes | . |
| T31318 | 408-412 | NN | denotes | IL-6 |
| T31317 | 405-407 | IN | denotes | of |
| T31316 | 390-404 | NNS | denotes | concentrations |
| T31315 | 385-389 | JJ | denotes | high |
| T31314 | 382-384 | TO | denotes | to |
| T31313 | 373-381 | NN | denotes | exposure |
| T31312 | 365-372 | JJ | denotes | chronic |
| T31311 | 359-364 | IN | denotes | after |
| T31310 | 352-358 | RB | denotes | mainly |
| T31309 | 344-351 | JJ | denotes | induced |
| T31308 | 341-343 | VB | denotes | be |
| T31307 | 338-340 | TO | denotes | to |
| T31306 | 330-337 | VBN | denotes | thought |
| T31305 | 326-329 | VBP | denotes | are |
| T31304 | 323-325 | NNP | denotes | RA |
| T31303 | 316-322 | JJ | denotes | active |
| T31302 | 313-315 | IN | denotes | in |
| T31301 | 299-312 | NNS | denotes | abnormalities |
| T31300 | 293-298 | DT | denotes | These |
| T31299 | 291-292 | . | denotes | . |
| T31298 | 286-291 | CD | denotes | SOCS3 |
| T31297 | 281-285 | IN | denotes | over |
| T31296 | 268-280 | NN | denotes | predominance |
| T31295 | 262-267 | CD | denotes | SOCS1 |
| T31294 | 257-261 | IN | denotes | with |
| T31293 | 246-256 | VBN | denotes | associated |
| T31292 | 237-245 | RB | denotes | possibly |
| T31291 | 234-236 | VBZ | denotes | is |
| T31290 | 224-233 | VBG | denotes | signaling |
| T31289 | 218-223 | CD | denotes | STAT3 |
| T31288 | 208-217 | JJ | denotes | defective |
| T31287 | 204-207 | DT | denotes | The |
| T31286 | 202-203 | . | denotes | . |
| T31285 | 192-202 | NN | denotes | activation |
| T31284 | 186-191 | CD | denotes | STAT3 |
| T31283 | 171-185 | JJ | denotes | IL-10-mediated |
| T31282 | 162-170 | VBN | denotes | impaired |
| T31281 | 158-161 | CC | denotes | and |
| T31280 | 142-157 | NN | denotes | phosphorylation |
| T31279 | 136-141 | CD | denotes | STAT3 |
| T31278 | 123-135 | VB | denotes | constitutive |
| T31277 | 120-122 | TO | denotes | to |
| T31276 | 116-119 | JJ | denotes | due |
| T31275 | 114-115 | , | denotes | , |
| T31274 | 104-114 | NN | denotes | production |
| T31273 | 98-103 | JJ | denotes | IFN-γ |
| T31272 | 95-97 | IN | denotes | of |
| T31271 | 84-94 | NN | denotes | inhibition |
| T31270 | 78-83 | NNP | denotes | IL-10 |
| T31269 | 75-77 | TO | denotes | to |
| T31268 | 64-74 | NN | denotes | resistance |
| T31267 | 58-63 | PRP$ | denotes | their |
| T31266 | 55-57 | IN | denotes | by |
| T31265 | 41-54 | VBN | denotes | characterized |
| T31264 | 37-40 | VBP | denotes | are |
| T31263 | 28-36 | NNS | denotes | patients |
| T31262 | 25-27 | NNP | denotes | RA |
| T31261 | 18-24 | JJ | denotes | active |
| T31260 | 13-17 | IN | denotes | from |
| T31259 | 7-12 | NNS | denotes | cells |
| T31258 | 5-6 | NNP | denotes | T |
| T31257 | 3-4 | CD | denotes | + |
| T31256 | 0-3 | CD | denotes | CD4 |
| T31370 | 684-685 | , | denotes | , |
| T31369 | 683-684 | NNP | denotes | ] |
| T31368 | 681-683 | CD | denotes | 51 |
| T31367 | 680-681 | NNP | denotes | [ |
| T31366 | 671-679 | NNS | denotes | patients |
| T31365 | 668-670 | NNP | denotes | RA |
| T31364 | 665-667 | IN | denotes | in |
| T31363 | 656-664 | VBN | denotes | reported |
| T31362 | 651-655 | VBN | denotes | been |
| R16585 | T31400 | T31401 | auxpass | be,awaited |
| R16586 | T31401 | T31419 | ccomp | awaited,demonstrated |
| R16587 | T31402 | T31419 | punct | ;,demonstrated |
| R16441 | T31256 | T31259 | nummod | CD4,cells |
| R16442 | T31257 | T31259 | nummod | +,cells |
| R16443 | T31258 | T31259 | compound | T,cells |
| R16444 | T31259 | T31265 | nsubjpass | cells,characterized |
| R16445 | T31260 | T31259 | prep | from,cells |
| R16446 | T31261 | T31263 | amod | active,patients |
| R16447 | T31262 | T31263 | compound | RA,patients |
| R16448 | T31263 | T31260 | pobj | patients,from |
| R16449 | T31264 | T31265 | auxpass | are,characterized |
| R16450 | T31265 | T31265 | ROOT | characterized,characterized |
| R16451 | T31266 | T31265 | agent | by,characterized |
| R16452 | T31267 | T31268 | poss | their,resistance |
| R16453 | T31268 | T31266 | pobj | resistance,by |
| R16454 | T31269 | T31268 | prep | to,resistance |
| R16455 | T31270 | T31271 | compound | IL-10,inhibition |
| R16456 | T31271 | T31269 | pobj | inhibition,to |
| R16457 | T31272 | T31271 | prep | of,inhibition |
| R16458 | T31273 | T31274 | compound | IFN-γ,production |
| R16459 | T31274 | T31272 | pobj | production,of |
| R16460 | T31275 | T31265 | punct | ",",characterized |
| R16461 | T31276 | T31265 | conj | due,characterized |
| R16462 | T31277 | T31278 | aux | to,constitutive |
| R16463 | T31278 | T31276 | xcomp | constitutive,due |
| R16464 | T31279 | T31280 | nummod | STAT3,phosphorylation |
| R16465 | T31280 | T31278 | dobj | phosphorylation,constitutive |
| R16466 | T31281 | T31278 | cc | and,constitutive |
| R16467 | T31282 | T31285 | amod | impaired,activation |
| R16468 | T31283 | T31285 | amod | IL-10-mediated,activation |
| R16469 | T31284 | T31283 | nummod | STAT3,IL-10-mediated |
| R16470 | T31285 | T31276 | pobj | activation,due |
| R16471 | T31286 | T31265 | punct | .,characterized |
| R16472 | T31287 | T31290 | det | The,signaling |
| R16473 | T31288 | T31290 | amod | defective,signaling |
| R16474 | T31289 | T31290 | nummod | STAT3,signaling |
| R16475 | T31290 | T31293 | nsubjpass | signaling,associated |
| R16476 | T31291 | T31293 | auxpass | is,associated |
| R16477 | T31292 | T31293 | advmod | possibly,associated |
| R16478 | T31293 | T31293 | ROOT | associated,associated |
| R16479 | T31294 | T31293 | prep | with,associated |
| R16480 | T31295 | T31296 | nummod | SOCS1,predominance |
| R16481 | T31296 | T31294 | pobj | predominance,with |
| R16482 | T31297 | T31296 | prep | over,predominance |
| R16483 | T31298 | T31297 | pobj | SOCS3,over |
| R16484 | T31299 | T31293 | punct | .,associated |
| R16485 | T31300 | T31301 | det | These,abnormalities |
| R16486 | T31301 | T31306 | nsubjpass | abnormalities,thought |
| R16487 | T31302 | T31301 | prep | in,abnormalities |
| R16488 | T31303 | T31304 | amod | active,RA |
| R16489 | T31304 | T31302 | pobj | RA,in |
| R16490 | T31305 | T31306 | auxpass | are,thought |
| R16491 | T31306 | T31306 | ROOT | thought,thought |
| R16492 | T31307 | T31309 | aux | to,induced |
| R16493 | T31308 | T31309 | auxpass | be,induced |
| R16494 | T31309 | T31306 | xcomp | induced,thought |
| R16495 | T31310 | T31311 | advmod | mainly,after |
| R16496 | T31311 | T31309 | prep | after,induced |
| R16497 | T31312 | T31313 | amod | chronic,exposure |
| R16498 | T31313 | T31311 | pobj | exposure,after |
| R16499 | T31314 | T31313 | prep | to,exposure |
| R16500 | T31315 | T31316 | amod | high,concentrations |
| R16501 | T31316 | T31314 | pobj | concentrations,to |
| R16502 | T31317 | T31316 | prep | of,concentrations |
| R16503 | T31318 | T31317 | pobj | IL-6,of |
| R16504 | T31319 | T31306 | punct | .,thought |
| R16505 | T31320 | T31322 | det | The,efficacy |
| R16506 | T31321 | T31322 | amod | limited,efficacy |
| R16507 | T31322 | T31334 | nsubjpass | efficacy,explained |
| R16508 | T31323 | T31322 | prep | of,efficacy |
| R16509 | T31324 | T31325 | amod | IL-10,treatment |
| R16510 | T31325 | T31323 | pobj | treatment,of |
| R16511 | T31326 | T31325 | prep | of,treatment |
| R16512 | T31327 | T31328 | compound | RA,patients |
| R16513 | T31328 | T31326 | pobj | patients,of |
| R16514 | T31329 | T31322 | appos | [,efficacy |
| R16515 | T31330 | T31331 | nummod | 50,] |
| R16516 | T31331 | T31334 | nsubjpass | ],explained |
| R16517 | T31332 | T31334 | aux | may,explained |
| R16518 | T31333 | T31334 | auxpass | be,explained |
| R16519 | T31334 | T31334 | ROOT | explained,explained |
| R16520 | T31335 | T31334 | prep | in,explained |
| R16521 | T31336 | T31335 | pobj | part,in |
| R16522 | T31337 | T31334 | agent | by,explained |
| R16523 | T31338 | T31339 | det | the,unresponsiveness |
| R16524 | T31339 | T31337 | pobj | unresponsiveness,by |
| R16525 | T31340 | T31339 | prep | to,unresponsiveness |
| R16526 | T31341 | T31340 | pobj | IL-10,to |
| R16527 | T31342 | T31341 | prep | of,IL-10 |
| R16528 | T31343 | T31344 | amod | inflammatory,cells |
| R16529 | T31344 | T31342 | pobj | cells,of |
| R16530 | T31345 | T31344 | punct | ",",cells |
| R16531 | T31346 | T31344 | prep | including,cells |
| R16532 | T31347 | T31348 | compound | T,cells |
| R16533 | T31348 | T31346 | pobj | cells,including |
| R16534 | T31349 | T31334 | punct | .,explained |
| R16535 | T31350 | T31363 | prep | On,reported |
| R16536 | T31351 | T31352 | det | the,contrary |
| R16537 | T31352 | T31350 | pobj | contrary,On |
| R16538 | T31353 | T31363 | punct | ",",reported |
| R16539 | T31354 | T31356 | det | the,efficacy |
| R16540 | T31355 | T31356 | amod | therapeutic,efficacy |
| R16541 | T31356 | T31363 | nsubjpass | efficacy,reported |
| R16542 | T31357 | T31356 | prep | of,efficacy |
| R16543 | T31358 | T31360 | amod | anti-IL-6,antibody |
| R16544 | T31359 | T31360 | compound | receptor,antibody |
| R16545 | T31360 | T31357 | pobj | antibody,of |
| R16546 | T31361 | T31363 | aux | has,reported |
| R16547 | T31362 | T31363 | auxpass | been,reported |
| R16548 | T31363 | T31363 | ROOT | reported,reported |
| R16549 | T31364 | T31363 | prep | in,reported |
| R16550 | T31365 | T31366 | compound | RA,patients |
| R16551 | T31366 | T31364 | pobj | patients,in |
| R16552 | T31367 | T31369 | nmod | [,] |
| R16553 | T31368 | T31369 | nummod | 51,] |
| R16554 | T31369 | T31363 | dobj | ],reported |
| R16555 | T31370 | T31369 | punct | ",",] |
| R16556 | T31371 | T31369 | cc | and,] |
| R16557 | T31372 | T31380 | nsubj | one,be |
| R16558 | T31373 | T31372 | prep | of,one |
| R16559 | T31374 | T31375 | det | the,effects |
| R16560 | T31375 | T31373 | pobj | effects,of |
| R16561 | T31376 | T31375 | prep | of,effects |
| R16562 | T31377 | T31378 | det | this,therapy |
| R16563 | T31378 | T31376 | pobj | therapy,of |
| R16564 | T31379 | T31380 | aux | may,be |
| R16565 | T31380 | T31363 | ccomp | be,reported |
| R16566 | T31381 | T31382 | aux | to,normalize |
| R16567 | T31382 | T31380 | xcomp | normalize,be |
| R16568 | T31383 | T31384 | compound | T,cells |
| R16569 | T31384 | T31382 | dobj | cells,normalize |
| R16570 | T31385 | T31382 | prep | through,normalize |
| R16571 | T31386 | T31387 | det | the,inhibition |
| R16572 | T31387 | T31385 | pobj | inhibition,through |
| R16573 | T31388 | T31387 | prep | of,inhibition |
| R16574 | T31389 | T31391 | amod | IL-6-dependent,activation |
| R16575 | T31390 | T31391 | nummod | STAT3,activation |
| R16576 | T31391 | T31388 | pobj | activation,of |
| R16577 | T31392 | T31363 | punct | .,reported |
| R16578 | T31393 | T31394 | advmod | More,specific |
| R16579 | T31394 | T31395 | amod | specific,therapy |
| R16580 | T31395 | T31401 | nsubjpass | therapy,awaited |
| R16581 | T31396 | T31395 | acl | targeting,therapy |
| R16582 | T31397 | T31398 | nummod | STAT3,activation |
| R16583 | T31398 | T31396 | dobj | activation,targeting |
| R16584 | T31399 | T31401 | aux | will,awaited |
| R16588 | T31403 | T31419 | prep | for,demonstrated |
| R16589 | T31404 | T31403 | pobj | example,for |
| R16590 | T31405 | T31419 | punct | ",",demonstrated |
| R16591 | T31406 | T31407 | det | the,induction |
| R16592 | T31407 | T31419 | nsubjpass | induction,demonstrated |
| R16593 | T31408 | T31407 | prep | of,induction |
| R16594 | T31409 | T31411 | det | the,gene |
| R16595 | T31410 | T31411 | nummod | SOCS3,gene |
| R16596 | T31411 | T31408 | pobj | gene,of |
| R16597 | T31412 | T31407 | punct | ",",induction |
| R16598 | T31413 | T31414 | det | the,efficacy |
| R16599 | T31414 | T31407 | conj | efficacy,induction |
| R16600 | T31415 | T31414 | prep | of,efficacy |
| R16601 | T31416 | T31415 | pobj | which,of |
| R16602 | T31417 | T31419 | aux | has,demonstrated |
| R16603 | T31418 | T31419 | auxpass | been,demonstrated |
| R16604 | T31419 | T31419 | ROOT | demonstrated,demonstrated |
| R16605 | T31420 | T31419 | prep | in,demonstrated |
| R16606 | T31421 | T31422 | compound | animal,models |
| R16607 | T31422 | T31420 | pobj | models,in |
| R16608 | T31423 | T31425 | nmod | [,] |
| R16609 | T31424 | T31425 | nummod | 37,] |
| R16610 | T31425 | T31422 | appos | ],models |
| R16611 | T31426 | T31419 | punct | .,demonstrated |
bionlp-st-ge-2016-test-tees
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31044 | 895-904 | Positive_regulation | denotes | induction |
| T31043 | 850-860 | Positive_regulation | denotes | activation |
| T31042 | 912-922 | Protein | denotes | SOCS3 gene |
| T31041 | 844-849 | Protein | denotes | STAT3 |
| T31040 | 784-793 | Positive_regulation | denotes | dependent |
| T31039 | 800-810 | Positive_regulation | denotes | activation |
| T31038 | 794-799 | Protein | denotes | STAT3 |
| T31037 | 779-783 | Protein | denotes | IL-6 |
| T31036 | 619-646 | Protein | denotes | anti-IL-6 receptor antibody |
| T31035 | 408-412 | Protein | denotes | IL-6 |
| T31034 | 286-291 | Protein | denotes | SOCS3 |
| T31033 | 262-267 | Protein | denotes | SOCS1 |
| T31032 | 218-223 | Protein | denotes | STAT3 |
| T31031 | 192-202 | Positive_regulation | denotes | activation |
| T31030 | 192-202 | Positive_regulation | denotes | activation |
| T31029 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T31028 | 104-114 | Gene_expression | denotes | production |
| T31027 | 186-191 | Protein | denotes | STAT3 |
| T31026 | 136-141 | Protein | denotes | STAT3 |
| T31025 | 98-103 | Protein | denotes | IFN-γ |
| T31024 | 78-83 | Protein | denotes | IL-10 |
| T31023 | 0-4 | Protein | denotes | CD4+ |
| R16245 | T31025 | T31028 | themeOf | IFN-γ,production |
| R16246 | T31026 | T31029 | themeOf | STAT3,phosphorylation |
| R16247 | T31027 | T31030 | themeOf | STAT3,activation |
| R16248 | T31028 | T31031 | themeOf | production,activation |
| R16249 | T31037 | T31040 | causeOf | IL-6,dependent |
| R16250 | T31038 | T31039 | themeOf | STAT3,activation |
| R16251 | T31039 | T31040 | themeOf | activation,dependent |
| R16252 | T31041 | T31043 | themeOf | STAT3,activation |
| R16253 | T31042 | T31044 | themeOf | SOCS3 gene,induction |
test3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30698 | 286-291 | Protein | denotes | SOCS3 |
| T30697 | 262-267 | Protein | denotes | SOCS1 |
| T30696 | 218-223 | Protein | denotes | STAT3 |
| T30695 | 186-191 | Protein | denotes | STAT3 |
| T30694 | 171-176 | Protein | denotes | IL-10 |
| T30693 | 136-141 | Protein | denotes | STAT3 |
| T30692 | 98-103 | Protein | denotes | IFN-γ |
| T30691 | 78-83 | Protein | denotes | IL-10 |
| T30690 | 1-3 | Protein | denotes | D4 |
| T30735 | 912-917 | Protein | denotes | SOCS3 |
| T30734 | 850-860 | Positive_regulation | denotes | activation |
| T30733 | 844-849 | Protein | denotes | STAT3 |
| T30732 | 800-810 | Positive_regulation | denotes | activation |
| T30731 | 794-799 | Protein | denotes | STAT3 |
| T30730 | 784-793 | Regulation | denotes | dependent |
| T30729 | 779-783 | Protein | denotes | IL-6 |
| T30728 | 765-775 | Negative_regulation | denotes | inhibition |
| T30727 | 624-637 | Protein | denotes | IL-6 receptor |
| T30726 | 526-531 | Protein | denotes | IL-10 |
| T30725 | 506-522 | Negative_regulation | denotes | unresponsiveness |
| T30724 | 438-443 | Protein | denotes | IL-10 |
| T30723 | 408-412 | Protein | denotes | IL-6 |
| T30722 | 344-351 | Positive_regulation | denotes | induced |
| T30721 | 286-291 | Protein | denotes | SOCS3 |
| T30720 | 262-267 | Protein | denotes | SOCS1 |
| T30719 | 218-223 | Protein | denotes | STAT3 |
| T30718 | 192-202 | Positive_regulation | denotes | activation |
| T30717 | 186-191 | Protein | denotes | STAT3 |
| T30716 | 177-185 | Positive_regulation | denotes | mediated |
| T30715 | 171-176 | Protein | denotes | IL-10 |
| T30714 | 162-170 | Negative_regulation | denotes | impaired |
| T30713 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T30712 | 136-141 | Protein | denotes | STAT3 |
| T30711 | 104-114 | Gene_expression | denotes | production |
| T30710 | 98-103 | Protein | denotes | IFN-γ |
| T30709 | 84-94 | Negative_regulation | denotes | inhibition |
| T30708 | 78-83 | Protein | denotes | IL-10 |
| T30707 | 0-3 | Protein | denotes | CD4 |
| T30706 | 912-917 | Protein | denotes | SOCS3 |
| T30705 | 844-849 | Protein | denotes | STAT3 |
| T30704 | 794-799 | Protein | denotes | STAT3 |
| T30703 | 779-783 | Protein | denotes | IL-6 |
| T30702 | 624-637 | Protein | denotes | IL-6 receptor |
| T30701 | 526-531 | Protein | denotes | IL-10 |
| T30700 | 438-443 | Protein | denotes | IL-10 |
| T30699 | 408-412 | Protein | denotes | IL-6 |
| R16211 | T30708 | T30709 | causeOf | IL-10,inhibition |
| R16212 | T30710 | T30711 | themeOf | IFN-γ,production |
| R16213 | T30711 | T30709 | themeOf | production,inhibition |
| R16214 | T30712 | T30713 | themeOf | STAT3,phosphorylation |
| R16215 | T30715 | T30716 | causeOf | IL-10,mediated |
| R16216 | T30716 | T30714 | themeOf | mediated,impaired |
| R16217 | T30717 | T30718 | themeOf | STAT3,activation |
| R16218 | T30718 | T30716 | themeOf | activation,mediated |
| R16219 | T30726 | T30725 | themeOf | IL-10,unresponsiveness |
| R16220 | T30729 | T30730 | causeOf | IL-6,dependent |
| R16221 | T30731 | T30732 | themeOf | STAT3,activation |
| R16222 | T30732 | T30730 | themeOf | activation,dependent |
| R16223 | T30733 | T30734 | themeOf | STAT3,activation |
testone
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30677 | 850-860 | Positive_regulation | denotes | activation |
| T30676 | 800-810 | Positive_regulation | denotes | activation |
| T30675 | 784-793 | Regulation | denotes | dependent |
| T30674 | 765-775 | Negative_regulation | denotes | inhibition |
| T30673 | 192-202 | Positive_regulation | denotes | activation |
| T30672 | 177-185 | Positive_regulation | denotes | mediated |
| T30671 | 162-170 | Negative_regulation | denotes | impaired |
| T30670 | 142-157 | Phosphorylation | denotes | phosphorylation |
| T30669 | 116-119 | Positive_regulation | denotes | due |
| T30668 | 104-114 | Gene_expression | denotes | production |
| T30667 | 84-94 | Negative_regulation | denotes | inhibition |
| T30666 | 912-917 | Protein | denotes | SOCS3 |
| T30665 | 844-849 | Protein | denotes | STAT3 |
| T30664 | 794-799 | Protein | denotes | STAT3 |
| T30663 | 779-783 | Protein | denotes | IL-6 |
| T30662 | 624-637 | Protein | denotes | IL-6 receptor |
| T30661 | 526-531 | Protein | denotes | IL-10 |
| T30660 | 438-443 | Protein | denotes | IL-10 |
| T30659 | 408-412 | Protein | denotes | IL-6 |
| T30658 | 286-291 | Protein | denotes | SOCS3 |
| T30657 | 262-267 | Protein | denotes | SOCS1 |
| T30656 | 218-223 | Protein | denotes | STAT3 |
| T30655 | 186-191 | Protein | denotes | STAT3 |
| T30654 | 171-176 | Protein | denotes | IL-10 |
| T30653 | 136-141 | Protein | denotes | STAT3 |
| T30652 | 98-103 | Protein | denotes | IFN-γ |
| T30651 | 78-83 | Protein | denotes | IL-10 |
| T30650 | 1-3 | Protein | denotes | D4 |
| R16199 | T30652 | T30668 | themeOf | IFN-γ,production |
| R16200 | T30653 | T30670 | themeOf | STAT3,phosphorylation |
| R16201 | T30654 | T30672 | causeOf | IL-10,mediated |
| R16202 | T30655 | T30673 | themeOf | STAT3,activation |
| R16203 | T30663 | T30675 | causeOf | IL-6,dependent |
| R16204 | T30664 | T30676 | themeOf | STAT3,activation |
| R16205 | T30665 | T30677 | themeOf | STAT3,activation |
| R16206 | T30668 | T30667 | themeOf | production,inhibition |
| R16207 | T30670 | T30669 | themeOf | phosphorylation,due |
| R16208 | T30672 | T30671 | themeOf | mediated,impaired |
| R16209 | T30673 | T30672 | themeOf | activation,mediated |
| R16210 | T30676 | T30675 | themeOf | activation,dependent |